The Exo AIpowered Series, or the X-Series as it is commonly referred to, is a revolutionary product in the medical world that is being hailed as the answer to a variety of problems faced by physicians. This innovative device is based on Silicon-based ultrasound transducer chips that help patients locate and treat their specific ailments. It is able to diagnose diseases and create treatment plans with the aid of artificial intelligence algorithms.
Artificial intelligence algorithms
Artificial intelligence is on the cusp of changing the way we live and work. In fact, there are significant deployments of AI technologies, including in transportation, healthcare, and national security. It is estimated that artificial intelligence technologies could boost global GDP by up to $14 trillion by 2030.
One of the most important aspects of the technology is the ability to sift huge amounts of data in real time. This will allow organizations to make more informed decisions. For example, a deep learning model will be trained on a specific image recognition task. The result is a machine that can detect small lesions in CT images and identify growths.
Another nifty little feature of artificial intelligence is that it can learn from its mistakes. In the case of an autonomous vehicle, for instance, it can adjust its guidance system to avoid hitting pedestrians.
Another thing artificial intelligence can do is determine the best route to take in an urban area. For instance, in the case of an autonomous car, the AI might decide that it’s safer to avoid traffic jams than to slog through them.
Silicon-based ultrasound transducer chips
Ultrasound-on-chip systems enable low-cost whole body imaging. This technology consists of a two-dimensional array of silicon-based MEMS ultrasonic sensors that are directly integrated with electronics on a CMOS chip.
Moreover, these sensors are characterized by high reliability and high performance. They are well-suited for high-volume applications. In addition, their low cost makes them very attractive for healthcare markets.
The first chip-based ultrasound transducer was developed by Hitachi in 2009. This sensor could only scan at one depth, but it did not have penetration capabilities. However, this technology is highly versatile and can be applied to a wide variety of applications.
After Hitachi’s initial ultrasound-on-chip system, other manufacturers began to design and develop chip-based ultrasound transducers. Some of these new products are able to capture three-dimensional information in high fidelity and at high speeds.
These sensors can be used to support a wide range of imaging modes, such as 2D imaging, 3D imaging, and multiorgan imaging. Furthermore, they can be used for non-invasive blood pressure monitoring and gesture recognition.
Funding haul of over $320 million
Exo, a Silicon Valley-based company developing innovative health information and diagnostic devices, has secured a new $220 million investment round. The financing will help Exo commercialize its handheld ultrasound device. The new device is designed for doctors to use at clinics, hospitals, and emergency rooms. It will utilize silicon-based ultrasound transducer chips and artificial intelligence algorithms to pinpoint the placement of IV lines and triage cardiac patients.
The device was initially developed by a team of nanotechnologists and chip designers. Exo also partnered with experts in consumer electronics and medical device development. For this project, the company used a series of scalable processes and materials to develop a handheld ultrasound device that can be used anywhere on the body. Once approved by the FDA, Exo will move forward with the commercialization of the product.
Conclusion
Exo, which has joined the Avidity Partners and Pura Vida Investments syndicates, will be using the investment to build an intuitive ultrasound workflow solution. This could lay the foundation for at-home exams.